Our vision is to provide life-long cures for patients suffering from serious diseases. #DaretoBeam #BeamTeam
Cambridge, MA
Joined December 2017
- Tweets822
- Following200
- Followers5.7K
- Likes46
Pinned Tweet
We're honored to share that Beam has been named a TIME100 Most Influential Company! @TIME recognized 100 companies charting an essential path forward & we're thrilled to have our work celebrated as we strive to break new ground to support patients suffering from serious diseases.
Another successful HallowBeam in the books! Thank you to our teams in Cambridge, MA & Durham, NC for bringing our values of fearless innovation and commitment to each other to life with your costumes and #BeamTeam spirit! #DaretoBeam
Today, Beam reported initial data from the ongoing Phase 1/2 clinical trial evaluating BEAM-301 for the treatment of glycogen storage disease type Ia. The data will be presented during a poster session at ESGCT.
Beam will host an investor webcast today at 8:00 a.m. ET to review the data presented. The live webcast can be accessed under “Events & Presentations” in the Investors section of Beam’s website. Read today’s press release here: investors.beamtx.com/news-re… #BeamTeam
A great fall day on the water! The #BeamTeam in North Carolina recently got together for a kayaking outing, enjoying the sunshine and great company. #DaretoBeam
Beam will present initial data from the ongoing Phase 1/2 clinical trial evaluating BEAM-301 for the treatment of glycogen storage disease type Ia (GSDIa) at the 33rd Annual Congress of the European Society of Gene and Cell Therapy (ESGCT).
Beam will host a live and webcast investor event on Tuesday, October 27, at 8:00 a.m. ET to review the data presented at this year’s congress. Read the press release here: investors.beamtx.com/news-re…
The Cambridge #BeamTeam was off to the races last week, competing in the Cambridge 5K! Great work to all the runners, and thanks to our Wellness team for organizing. 🏃♀️ #DaretoBeam
Beam was honored to recently host U.S. Rep. Valerie Foushee to our Durham manufacturing facility. As a proud member of the North Carolina life sciences community, we’re committed to working with policymakers to support patient access to potential innovative gene therapies.
Teamwork on and off the course! We’re proud of our Beam Team in North Carolina for coming together to participate in the Pharma Cup Tournament for the second year in a row. Thank you to everyone who represented Beam! #BeamTeam #DaretoBeam
Beam is proud to have contributed to @alliancerm's new gene editing playbook, A Platform Framework for Gene Editing Drug Development. Read it here: alliancerm.org/gene-editing-… #BeamTeam #DaretoBeam
The Cambridge #BeamTeam recently united in support of two patient communities through a Walk for Sickle Cell Disease during Sickle Cell Awareness Month and a bike ride benefiting the @Alpha1Foundation Riding for a Reason campaign.
We’re grateful for the opportunity to raise awareness for the #sicklecell and #Alpha1 communities. #DaretoBeam
The Cambridge #BeamTeam said goodbye to summer and hello to fall at @KimballFarm last week!
As we continue to work hard to advance our mission, it’s nice to take moments like these to connect with each other and celebrate all we’ve accomplished as a team, putting our company value of being “committed to each other” into practice and having a little fun while doing it!
As always, @LS_Cares Mini Golf for Good event was a hole in one! The Cambridge #BeamTeam had a great time, and we appreciate the opportunity to partner with Life Science Cares. #DaretoBeam
September is #SickleCellAwarenessMonth, so we wanted to take the opportunity to ask a few members of the #BeamTeam the question, “Why is it important that we research sickle cell disease?” Hear what they had to say in the video below. #DaretoBeam #sicklecelldisease
Are you attending one of the upcoming career fairs below? Come visit the #BeamTeam in North Carolina – we’d love to meet you! #DaretoBeam
Beam’s Chief Scientific Officer Gopi Shanker will be participating as an expert speaker & day one chair at the 7th Annual Genome Editing Therapeutics Summit on September 29-30 in Boston, MA.
We look forward to discussing with the gene editing community how we can all address developmental, manufacturing, and regulatory barriers to realize gene editing’s full potential! #DaretoBeam #BeamTeam